Based on its MyoScreen™ platform, CYTOO developed:
- A myosteatosis model to identify new targets and drugs
- A robust lipid accumulation screening assay for target identification and siRNA screening
Our lipid accumulation assay is particularly relevant for determining efficacy of small molecules to reduce lipid content and provides spatial, quantitative, and dynamic information that other biochemical methods can’t fully capture.
Key capabilities:
📍 Spatial resolution — seeing where lipids go
⏱️ Dynamic monitoring — tracking uptake over time
📊 Quantitative and single-cell information
🔍 Mechanistic insight into metabolic pathways
💊 Drug screening and disease modeling
🧪 Reduced sample destruction and multiplexing
